GNCA
$2.71
Genocea Biosciences
$.01
.37%
GNCA
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus:  ($0.24)
Revenue:  N/A
Thursday
Oct 22
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Thursday, July 23, 2020

What do you expect when GNCA reports earnings?
Beat
Meet
Miss

Where is GNCA's stock price going from here?
Up
Flat
Down
Stock chart of GNCA
Analysts
Summary of analysts' recommendations for GNCA
Score
Grade
Pivots
Resistance
$3.15
$3.05
$2.88

$2.78

Support
$2.61
$2.51
$2.34
Tweet
Growth
Peers
InterCeptRegeneron PharmaceuticalsVertex PharmaceuticalsBioMarin PharmaceuticalJohnson & JohnsonZoetisBristol-Myers SquibbUltragenyx PharmaceuticalCatalentMerck & Co.